Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

Similar articles for PubMed (Select 24826969)

1.

Ecto-domain phosphorylation promotes functional recovery from spinal cord injury.

Suehiro K, Nakamura Y, Xu S, Uda Y, Matsumura T, Yamaguchi Y, Okamura H, Yamashita T, Takei Y.

Sci Rep. 2014 May 15;4:4972. doi: 10.1038/srep04972.

2.
3.

The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.

Guo X, Zahir T, Mothe A, Shoichet MS, Morshead CM, Katayama Y, Tator CH.

Cell Transplant. 2012;21(6):1177-97. doi: 10.3727/096368911X612503. Epub 2012 Jan 10.

PMID:
22236767
4.

Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.

Li S, Liu BP, Budel S, Li M, Ji B, Walus L, Li W, Jirik A, Rabacchi S, Choi E, Worley D, Sah DW, Pepinsky B, Lee D, Relton J, Strittmatter SM.

J Neurosci. 2004 Nov 17;24(46):10511-20.

5.

Blockade of Nogo receptor ligands promotes functional regeneration of sensory axons after dorsal root crush.

Harvey PA, Lee DH, Qian F, Weinreb PH, Frank E.

J Neurosci. 2009 May 13;29(19):6285-95. doi: 10.1523/JNEUROSCI.5885-08.2009.

6.

Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.

Li S, Strittmatter SM.

J Neurosci. 2003 May 15;23(10):4219-27.

7.

Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.

Yu P, Huang L, Zou J, Yu Z, Wang Y, Wang X, Xu L, Liu X, Xu XM, Lu PH.

Neurobiol Dis. 2008 Dec;32(3):535-42. doi: 10.1016/j.nbd.2008.09.012. Epub 2008 Sep 30.

PMID:
18930141
8.

A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice.

Steward O, Sharp K, Yee KM, Hofstadter M.

Exp Neurol. 2008 Feb;209(2):446-68. doi: 10.1016/j.expneurol.2007.12.010. Epub 2007 Dec 23.

9.

Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury.

Li S, Kim JE, Budel S, Hampton TG, Strittmatter SM.

Mol Cell Neurosci. 2005 May;29(1):26-39.

10.

Recovery from chronic spinal cord contusion after Nogo receptor intervention.

Wang X, Duffy P, McGee AW, Hasan O, Gould G, Tu N, Harel NY, Huang Y, Carson RE, Weinzimmer D, Ropchan J, Benowitz LI, Cafferty WB, Strittmatter SM.

Ann Neurol. 2011 Nov;70(5):805-21. doi: 10.1002/ana.22527.

11.

A neonatal mouse spinal cord injury model for assessing post-injury adaptive plasticity and human stem cell integration.

Boulland JL, Lambert FM, Züchner M, Ström S, Glover JC.

PLoS One. 2013 Aug 19;8(8):e71701. doi: 10.1371/journal.pone.0071701. eCollection 2013.

12.

Nogo-66 receptor antagonist peptide promotes axonal regeneration.

GrandPré T, Li S, Strittmatter SM.

Nature. 2002 May 30;417(6888):547-51.

PMID:
12037567
13.

The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.

Wang YT, Lu XM, Zhu F, Huang P, Yu Y, Zeng L, Long ZY, Wu YM.

Biomaterials. 2011 Nov;32(31):7988-98. doi: 10.1016/j.biomaterials.2011.07.009. Epub 2011 Jul 23.

PMID:
21784510
14.

Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways.

Wang X, Hasan O, Arzeno A, Benowitz LI, Cafferty WB, Strittmatter SM.

Exp Neurol. 2012 Sep;237(1):55-69. doi: 10.1016/j.expneurol.2012.06.009. Epub 2012 Jun 21.

15.

Inhibition of Nogo-66 receptor 1 enhances recovery of cognitive function after traumatic brain injury in mice.

Tong J, Liu W, Wang X, Han X, Hyrien O, Samadani U, Smith DH, Huang JH.

J Neurotrauma. 2013 Feb 15;30(4):247-58. doi: 10.1089/neu.2012.2493. Epub 2013 Feb 4.

16.

Delayed Nogo receptor therapy improves recovery from spinal cord contusion.

Wang X, Baughman KW, Basso DM, Strittmatter SM.

Ann Neurol. 2006 Nov;60(5):540-9.

17.

Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity.

Akbik F, Cafferty WB, Strittmatter SM.

Exp Neurol. 2012 May;235(1):43-52. doi: 10.1016/j.expneurol.2011.06.006. Epub 2011 Jun 15. Review.

18.

ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats.

Hu LY, Sun ZG, Wen YM, Cheng GZ, Wang SL, Zhao HB, Zhang XR.

Neuroscience. 2010 Sep 1;169(3):1046-62. doi: 10.1016/j.neuroscience.2010.05.046. Epub 2010 Jun 1.

PMID:
20678995
19.

Activity-induced and developmental downregulation of the Nogo receptor.

Josephson A, Trifunovski A, Schéele C, Widenfalk J, Wahlestedt C, Brené S, Olson L, Spenger C.

Cell Tissue Res. 2003 Mar;311(3):333-42. Epub 2003 Jan 31.

PMID:
12658441
20.

TAT-NEP1-40 as a novel therapeutic candidate for axonal regeneration and functional recovery after stroke.

Gou X, Wang Q, Yang Q, Xu L, Xiong L.

J Drug Target. 2011 Feb;19(2):86-95. doi: 10.3109/10611861003733961. Epub 2010 Apr 1.

PMID:
20367026
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk